Convergence Investment Partners, LLC

Position in VTRS — Viatris Inc

CIK 1456133 PALM BEACH GARDENS, FL

Back to VTRS Full portfolio

Position in VTRS

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,187,363

+$171,357 QoQ

Shares Held

74,771

-0.6% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#301

of 1,022 holders

Holding Since

Jun 2022

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Convergence Investment Partners, LLC holds $12,621,502 across 3 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	344,765	$5,967,882
2	NBIX	Neurocrine Biosciences Inc	32,433	$5,466,257
3	VTRS	Viatris Inc This page	74,771	$1,187,363

All Filings in VTRS

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,187,363	74,771	-0.6%	Shares	Sole	2026-07-31
2026-03-31	$1,016,006	75,204	+3.3%	Shares	Sole	2026-05-07
2024-06-30	$773,778	72,792	+39.0%	Shares	Sole	2024-08-01
2024-03-31	$625,453	52,383	+133.4%	Shares	Sole	2024-05-03
2023-12-31	$243,014	22,439	+49.5%	Shares	Sole	2024-02-05
2023-03-31	$144,386	15,009	+35.0%	Shares	Sole	2023-05-09
2022-06-30	$116,426	11,120	—	Shares	Sole	2022-08-05
No filing history on record for this holder in this stock.